These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 25275736

  • 21. Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis: An Interim Analysis.
    Gupta AK, Cooper EA.
    Skin Therapy Lett; 2021 Jan; 26(1):5-10. PubMed ID: 33539062
    [Abstract] [Full Text] [Related]

  • 22. Long-Term Follow-up of Onychomycosis Patients Treated With Efinaconazole.
    Pollak RA, Ilie C.
    J Drugs Dermatol; 2017 Dec 01; 16(12):1269-1273. PubMed ID: 29240863
    [Abstract] [Full Text] [Related]

  • 23. Labeled use of efinaconazole topical solution 10% in treating onychomycosis in children and a review of the management of pediatric onychomycosis.
    Gupta AK, Venkataraman M, Shear NH, Piguet V.
    Dermatol Ther; 2020 Jul 01; 33(4):e13613. PubMed ID: 32418289
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy of combination therapy with efinaconazole 10% solution and 1064 nm Nd:YAG laser for treatment of toenail onychomycosis.
    Bonhert K, Dorizas A, Sadick NS.
    J Cosmet Laser Ther; 2019 Jul 01; 21(3):179-183. PubMed ID: 30052090
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Efinaconazole: a new topical treatment for onychomycosis.
    Gupta AK, Simpson FC.
    Skin Therapy Lett; 2014 Jul 01; 19(1):1-4. PubMed ID: 24570290
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Safety and pharmacokinetics of efinaconazole 10% solution in healthy volunteers and patients with severe onychomycosis.
    Jarratt M, Siu WJ, Yamakawa E, Kodera N, Pillai R, Smith K.
    J Drugs Dermatol; 2013 Sep 01; 12(9):1010-6. PubMed ID: 24002148
    [Abstract] [Full Text] [Related]

  • 32. Efinaconazole and Tavaborole.
    Poulakos M, Grace Y, Machin JD, Dorval E.
    J Pharm Pract; 2017 Apr 01; 30(2):245-255. PubMed ID: 26873506
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V, Pillai R.
    J Pharm Sci; 2015 Jul 01; 104(7):2177-82. PubMed ID: 25940933
    [Abstract] [Full Text] [Related]

  • 36. Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
    Rosen T, Stein Gold LF.
    Semin Cutan Med Surg; 2016 Mar 01; 35(3 Suppl 3):S51-5. PubMed ID: 27074700
    [Abstract] [Full Text] [Related]

  • 37. Report of a case of a dermatophytoma successfully treated with topical efinaconazole 10% solution.
    Cantrell W, Canavan T, Elewski B.
    J Drugs Dermatol; 2015 May 01; 14(5):524-6. PubMed ID: 25942674
    [Abstract] [Full Text] [Related]

  • 38. Managing Assessments and Expectations: Patient Responses Following Therapy With Efinaconazole Topical Solution, 10%.
    Bhatia N.
    J Drugs Dermatol; 2015 Jul 01; 14(7):694-8. PubMed ID: 26151785
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy and Safety of Efinaconazole 10% Solution in the Treatment of Onychomycosis in Diabetic Patients.
    Shofler D, Hamedani E, Seun J, Navarrete R, Thamby R, Harkless L.
    Clin Podiatr Med Surg; 2020 Apr 01; 37(2):401-407. PubMed ID: 32146992
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.